SCHEMBL19966865

SCHEMBL19966865

O=C(Nc1cccc(Nc2nccc(-c3ccccc3)n2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 4/20 0.68
MAPK14 Q16539 1/20 0.68
JAK2 O60674 3/20 0.57
RAF1 P04049 2/20 0.57
GSK3B P49841 4/20 0.56
ABL1 P00519 3/20 0.54
BCR P11274 3/20 0.54
SRC P12931 3/20 0.54
PDGFRB P09619 2/20 0.54
PDGFRA P16234 2/20 0.54
PRKD3 O94806 1/20 0.54
PRKCG P05129 1/20 0.54
PRKCB P05771 1/20 0.54
PRKCA P17252 1/20 0.54
PRKCH P24723 1/20 0.54
PRKCI P41743 1/20 0.54
PRKCE Q02156 1/20 0.54
PRKCQ Q04759 1/20 0.54
PRKCZ Q05513 1/20 0.54
PRKCD Q05655 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21074032 0.93 BRAF (0.64) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL21074128 0.91 BRAF (0.65) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL21074040 0.89 BRAF (0.60) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL21074039 0.89 BRAF (0.60) BRAFMAPK14JAK2RAF1ABL1
SCHEMBL19966882 0.89 BRAF (0.62) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL21074046 0.89 BRAF (0.64) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL21116138 0.87 BRAF (0.66) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL19966957 0.85 BRAF (0.57) BRAFMAPK14JAK2RAF1GSK3B
SCHEMBL19966893 0.85 BRAF (0.57) BRAFMAPK14JAK2RAF1KDR
SCHEMBL19966813 0.85 ABL1 (0.59) JAK2GSK3BABL1BCRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10793527-B2 Adenosine monophosphate-activated protein kinase agonist NATIONAL YANG-MING UNIVERSITY (TW) 2020-10-06 US disclosed
US-20190194142-A1 AN ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE AGONIST NATIONAL YANG-MING UNIVERSITY (TW) 2019-06-27 US disclosed
WO-2018045969-A1 COMPOUND FOR ACTIVATING ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE 法玛科技顾问股份有限公司 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194142-A1 AN ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE AGONIST PRKAG1, PRKAG2, PRKAB1 BRAF 1090/4885MAPK14 557/4885JAK2 1456/4885
US-10793527-B2 Adenosine monophosphate-activated protein kinase agonist PRKAG1, PRKAG2, PRKAB1 BRAF 1036/4885MAPK14 565/4885JAK2 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.